International Advisory Committee on Clinical Trials in Multiple Sclerosis 2023, ' Multiple sclerosis progression : time for a new mechanism-driven framework ', The Lancet Neurology, vol. 22, no. 1, pp. 78-88 . https://doi.org/10.1016/S1474-4422(22)00289-7